≥99% HPLC Each ComponentMS ConfirmedJanoshik COAQSC Exclusive Formula5-Region Shipping
What is Adamax?
Adamax is a QSC proprietary multi-peptide cognitive research blend combining PE-22-28, Semax, and Selank in a single pre-formulated vial. It targets FGFR1 (fibroblast growth factor receptor), MC4R (melanocortin), and GABAergic neuroplasticity pathways simultaneously — creating a multi-mechanism nootropic stack unavailable from any other supplier. Exclusive QSC formulation, Janoshik COA verified.
Components
PE-22-28 — FGFR1 / TREK-1 Inhibitor
Cyclic spadin analog. Blocks TREK-1 potassium channels and activates FGFR1 signalling — antidepressant activity in rodent models, BDNF upregulation, neurogenesis. Rapid-onset mechanism distinct from SSRI pathways.
All three components show independent neuroprotection in ischaemia/oxidative stress models. Combined blend for comprehensive multi-target neuroprotection research.
Mood & Anxiety Research
Semax antidepressant + Selank anxiolytic + PE-22-28 TREK-1 inhibition — three independent mood-relevant mechanisms in one model.
Specifications
Product
Adamax — QSC Cognitive Research Blend
Components
PE-22-28 + Semax + Selank (pre-formulated)
Format
Lyophilised — 10mg per vial
Purity
≥99% HPLC per component, Janoshik COA
Storage
−20°C lyophilised; 4°C reconstituted, use within 7 days
Frequently Asked Questions
What is Adamax?
Adamax is a QSC proprietary cognitive peptide blend combining PE-22-28, Semax, and Selank for simultaneous FGFR1, MC4R, and GABAergic activation. Exclusive to QSC.
What makes Adamax different from buying the compounds separately?
Pre-formulated, pre-verified blend in a single vial. Janoshik COA covers all components. No separate reconstitution required.
